Malignant Head and Neck Neoplasm clinical trials
Showing 101–135 of 135 active trials. Describe your situation to see which ones you may be eligible for.
- Comprehensive Outcomes for After Cancer Health
- Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
- Feasibility Study of CBCT for IGRT in Cancer Patients
- Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- Improving Care for Rural Patients With Solid Tumors
- Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- EMST in Patients Undergoing CRT for HNCA
- Better Options for Chronic Cancer Pain
- Evaluating Avive+ Soft Tissue Matrix for Prevention of Superficial Radial Nerve Morbidity Following Radial Forearm Free Flap Harvest
- [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers
- RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer
- Symptom Management to Improve Completion of Patient-reported Outcome Measures
- Preventing Lymphedema in Patients Undergoing Surgical Treatment for Head and Neck Cancer Through Vein Reconstruction
- A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck
- Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
- Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer Trial
- Maximizing Quality of Life After Cancer Through Rehabilitation
- Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging
- Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)
- NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
- Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort
- Improving PRO for Patients With Cancer Using ECAs and Data Visualization
- Assessing Impact of Early Physiotherapy on Lymphatic Dysfunction in Head and Neck Cancer Survivorship
- A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
- Clinical Trial to Treat Stage IV Cancer Patients
- Social Needs App for Oncology Patients Phase II
- Effects of Flavor Modification for Management of Radiation Induced Dysgeusia
- Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
- Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy
- Comparing Two Ways to Manage Head and Neck Lymphedema
- Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection
- A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- Early Feeding After Oral Cavity Reconstruction
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.